Magdalena B Flak

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. pmc p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
    Magdalena B Flak
    Centre for Molecular Oncology and Imaging, Institute of Cancer, Barts and the London School of Medicine, Queen Mary University of London, London EC1 M 6BQ, UK
    Mol Cancer 9:175. 2010
  2. pmc Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells
    Claire M Connell
    Centre for Molecular Oncology and Imaging, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
    J Clin Invest 121:1283-97. 2011

Collaborators

  • Iain A McNeish
  • Claire M Connell
  • Atsushi Shibata
  • Laura A Tookman
  • Michelle Lockley
  • Sally P Wheatley
  • Katrina J Pirlo
  • Kyra M Archibald

Detail Information

Publications2

  1. pmc p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
    Magdalena B Flak
    Centre for Molecular Oncology and Imaging, Institute of Cancer, Barts and the London School of Medicine, Queen Mary University of London, London EC1 M 6BQ, UK
    Mol Cancer 9:175. 2010
    ..These results highlight that host cell factors beyond simple infectivity can influence the efficacy of oncolytic adenoviruses. p21 expression may be an important biomarker of response in clinical trials...
  2. pmc Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells
    Claire M Connell
    Centre for Molecular Oncology and Imaging, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
    J Clin Invest 121:1283-97. 2011
    ....